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still poorly understood, is that of IBD. Young et al. (2011) argue that 
IBD should be considered a cluster of related diseases, that detailed 
time series analysis of luminal and mucosa-associated microbial 
communities are required, and that a comprehensive understand-
ing of the relevant confounding variables in human clinical studies 
will be necessary. Perhaps most importantly, many technical aspects 
must be considered in designing a given study, spanning the meth-
ods used for sampling patients, the development of appropriate 
animal models, the platform used for sequencing, and the nascent 
development of bioinformatic methods for the concomitant analy-
sis of DNA, RNA, proteins, metabolites, and spatial organization. Of 
note, recent studies are beginning to reveal the diversity of microbial 
eukaryotes living in the human gut, a largely underexplored com-
ponent of our microbiome with potential implications for health 
and disease (Parfrey et al., 2011).
Another key method necessary to move beyond largely descrip-
tive sequence-based analyses of the gut microbiome is functional 
metagenomics; the screening of metagenomic libraries created by 
cloning community DNA into a suitable host strain, allowing causal 
links between genes from uncultured organisms and their func-
tion (Moore et al., 2011). To date, studies of the human gut and 
other environments have already identified novel genes for antibi-
otic resistance, fiber degradation, bile salt hydrolysis, and immune 
modulation (Moore et al., 2011).
Pfeiffer and Sonnenburg (2011) highlight the role of the gut 
microbiome in regulating host susceptibility to infection from path-
ogenic bacteria and viruses. For example, infection by Clostridium 
difficile and Salmonella sp. can be triggered by antibiotic treatment, 
while other pathogens may alter the host immune response to pro-
mote persistent colonization. Furthermore, the gut microbiome 
may play an important role in viral infection: e.g., influenza, den-
gue, adenovirus, and HIV. Future studies promise to address the 
underlying mechanisms behind these phenomena, such as directly 
modifying viral particles, recruiting immune effectors that promote 
viral replication, or modulating host immunity to permit viral rep-
lication (Pfeiffer and Sonnenburg, 2011).
The human microbiome is also thought to play a critical role in 
both sides of the energy balance equation, allowing the digestion 
of complex substrates inaccessible to our own human enzymes 
and promoting the accumulation of body fat. Intriguingly, stud-
ies in livestock suggest that antibiotics can be used to alter weight 
gain (Lin, 2011). Thomas et al. (2011) review their recent results 
highlighting the potential for a new type of impact of the diet on 
our gut microbiome – the lateral transfer of genes from transient 
microbes ingested from the diet to our resident microorganisms. 
These genetic swaps could potentially have a lasting impact on the 
ability to digest a given diet, enabling an entrenched community to 
adapt to changes in diet. In two original research articles published 
Humans and other mammals have co-evolved with trillions of micro-
organisms (the microbiota), whose aggregate genomes (the microbi-
ome) contribute functions that are not encoded by our own human 
genome. Recent developments in the emerging field of metagenomics 
have enabled an unprecedented description of organismal, genetic, 
transcriptional, proteomic, and metabolic diversity across a wide 
range of body habitats, spawning multiple ongoing international 
human microbiome projects. These largely sequencing-driven stud-
ies, along with mechanistic studies in vitro and in animal models, 
have emphasized the role the human microbiome plays in health 
and disease, including inflammatory bowel disease (IBD), metabolic 
syndrome, autoimmune disorders, and even cancer.
Here, in this “Research Topic” collection of reviews, perspec-
tives, and original research articles, leading researchers in the field 
have highlighted recent developments in our appreciation of the 
structure and function of the human microbiome, spanning a 
wide range of topics including immune development (Derrien 
et al., 2011; Kosiewicz et al., 2011; Pfeiffer and Sonnenburg, 2011; 
Reading and Kasper, 2011; Smith and Garrett, 2011), IBD (Young 
et al., 2011), nutrition, and obesity (Geurts et al., 2011; Li et al., 
2011; Lin, 2011; Thomas et al., 2011), and novel methods for ana-
lyzing complex microbial communities (Moore et al., 2011; Parfrey 
et al., 2011).
First, we present a series of reviews highlighting that the human 
immune system is intimately linked to the gut microbiome; the 
gut microbiota influences immune development, susceptibility to 
infection from pathogens, and inflammation (Kosiewicz et al., 2011; 
Reading and Kasper, 2011; Smith and Garrett, 2011). Through the 
use of gnotobiotic mouse models colonized with cultured isolates 
from the human gut, recent studies have highlighted the role specific 
members of this complex community can play in programming 
the immune system. For example, segmented filamentous bacteria 
can promote the expansion of IL-17 cells, Bacteroides fragilis can 
alleviate colitis in animal models, and some Clostridium strains can 
promote the expansion of regulatory T-cells. Moving forward, the 
study of gnotobiotic mice colonized with more complex commu-
nities derived from human or animal donors, may provide insight 
into the mechanisms by which different microbial communities 
can alter host immunity (Reading and Kasper, 2011). In an original 
research article, Derrien et al. (2011) demonstrate that Akkermansia 
muciniphila, a bacterium specialized for the degradation of host 
mucin (a glycoprotein abundant in the mucosal layer of the gut), 
is able to alter mucosal gene expression, up-regulating genes for 
immune response and cell fate determination, with potentially 
important implications for immune tolerance.
Together, these interactions between the gut microbiome and 
immune system could contribute to multiple diseases involving 
aberrant inflammation. The most commonly studied case, although 
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here, animal models are used to further explore this relationship 
between the gut microbiome and energy balance. Geurts et al. 
(2011) demonstrate that the gut microbiota and endocannabinoid 
system are modified in obese and diabetic leptin-resistant db/db 
mice, although follow-on studies are necessary to determine if the 
gut microbiota is contributing to or responding to this phenotype. 
Finally, Li et al. (2011) use rats to show that bariatric surgery results 
in an altered microbiota and metabolome, coupled to increased 
cytotoxicity.
Together, these original research articles, reviews, and perspec-
tives emphasize the importance of the microbiome across many 
aspects of human health and disease. Although many important 
questions remain unanswered, the pace of discovery continues to 
accelerate, as a wide range of scientists across many disciplines are 
beginning to turn their expertise toward studying this complex 
and fascinating ecosystem. In the near future, these studies may 
lead to new diagnostic tools and therapies targeting our microbial 
communities. In a broader sense, they also provide a new per-
spective of our own human body, as an often imperceptible, but 
always ongoing, dialog with our trillions of microbial partners.
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